Concerns About Genetic Risk Testing for Opioid Use Disorder

Files
Hatoum2025Concerns-AAM.pdf (40.33 KB)
Date
2025
Authors
Hatoum, Alexander S.
Davis, Christal N.
Kember, Rachel L.
Johnstone, Mandy
Oslin, David W.
Zinkstok, Janneke R.
Burmeister, Margit
Ethics, Position, and Public Policy Committee of the International Society of Psychiatric Genetics
Board of Directors of the International Society of Psychiatric Genetics
Agrawal, Arpana
Kranzler, Henry R.
Edenberg, Howard J.
Gelernter, Joel
Docherty, Anna R.
Lencz, Todd
Language
American English
Embargo Lift Date
Department
Biochemistry and Molecular Biology, School of Medicine
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Elsevier
Can't use the file because of accessibility barriers? Contact us with the title of the item, permanent link, and specifics of your accommodation need.
Abstract
Description
Keywords
Genetic testing, Addictive disorder, Risk, Genetic variants, Opioid use disorder
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Hatoum AS, Davis CN, Kember RL, et al. Concerns about genetic risk testing for opioid use disorder. Lancet Psychiatry. 2025;12(2):94-95. doi:10.1016/S2215-0366(24)00310-9
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
The Lancet: Psychiatry
Rights
Publisher Policy
Source
PMC
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Permanent Link
https://hdl.handle.net/1805/49518
DOI
https://doi.org/10.1016/S2215-0366(24)00310-9
Version
Author's manuscript
Full Text Available at
This item is under embargo {{howLong}}
Collections
Open Access Policy Articles